Purpose: Murine models of pancreatic cancer with damp-heat syndrome were established based on two methods to explore the differences in the composition of intestinal flora and to seek characteristic genera with potential for model evaluation.
Methods: In our study, thirty-four C57BL/6J male mice were randomly divided into a control group (Con), a model group (Mod), a classic damp-heat syndrome group (CDHS), and a climate-chamber group (CC). CDHS and CC groups were fed with a high-fat diet and glucose water, while the CDHS group was given 2.4 g/kg alcohol by gavage for 10 days, and the CC group was placed in a climatic chamber with a set temperature of (32 ± 1) °C and humidity of (92 ± 2)% for 10 days. The Mod group, CDHS group, and CC group underwent tumor-building experiments on day 11. Tumorigenicity was then assessed twice a week. After 4 weeks, feces, colon tissue, and tumor tissue were taken from the mice and were tested, and the mice were euthanized afterwards.
Results: Mice in the CDHS and CC groups showed symptoms similar to the clinical damp-heat syndrome observed in traditional Chinese medicine (TCM), and exhibited a worse general condition and more rapid tumor growth trend than those in the Mod group. The pathological examination indicated that inflammation was prevalent in the CDHS and CC groups. Both groups had a disrupted intestinal barrier and an overgrowth of pathogenic bacteria such as c_Gammaproteobacteria, o_Enterobacteriales, and g_Bacteroides. Their microbiota composition showed greater diversity.
Conclusions: Intestinal flora may have a promising future in the discovery of indicators for evaluating a model of damp-heat syndrome in pancreatic cancer.
目的:基于两种方法建立胰腺癌湿热综合征小鼠模型,以探索肠道菌群组成的差异,并寻找具有模型评估潜力的特征菌属:在我们的研究中,34只C57BL/6J雄性小鼠被随机分为对照组(Con)、模型组(Mod)、典型湿热综合征组(CDHS)和气候箱组(CC)。CDHS组和CC组喂食高脂饮食和葡萄糖水,CDHS组灌胃2.4克/千克酒精10天,CC组置于设定温度为(32±1)℃、湿度为(92±2)%的气候箱中10天。Mod 组、CDHS 组和 CC 组在第 11 天进行肿瘤形成实验。然后每周评估肿瘤致病性两次。4 周后,对小鼠的粪便、结肠组织和肿瘤组织进行检测,随后对小鼠实施安乐死:结果:CDHS组和CC组小鼠表现出类似中医临床湿热证的症状,与Mod组小鼠相比,全身状况更差,肿瘤生长趋势更快。病理检查显示,CDHS 组和 CC 组普遍存在炎症。两组患者的肠道屏障均被破坏,致病菌过度生长,如c_甘露聚糖杆菌、o_肠杆菌和g_杆菌。他们的微生物群组成显示出更大的多样性:肠道菌群在发现评估胰腺癌湿热综合征模型的指标方面前景广阔。
{"title":"Characteristics of Gut Microbiome in the Murine Model of Pancreatic Cancer with Damp-Heat Syndrome.","authors":"Yangbo Tong, Fang Han, Mengyao Liu, Tianyu Xu, Aiqin Zhang, Jiangjiang Qin, Yuhua Zhang, Xiang Qian","doi":"10.3390/biomedicines12102360","DOIUrl":"10.3390/biomedicines12102360","url":null,"abstract":"<p><strong>Purpose: </strong>Murine models of pancreatic cancer with damp-heat syndrome were established based on two methods to explore the differences in the composition of intestinal flora and to seek characteristic genera with potential for model evaluation.</p><p><strong>Methods: </strong>In our study, thirty-four C57BL/6J male mice were randomly divided into a control group (Con), a model group (Mod), a classic damp-heat syndrome group (CDHS), and a climate-chamber group (CC). CDHS and CC groups were fed with a high-fat diet and glucose water, while the CDHS group was given 2.4 g/kg alcohol by gavage for 10 days, and the CC group was placed in a climatic chamber with a set temperature of (32 ± 1) °C and humidity of (92 ± 2)% for 10 days. The Mod group, CDHS group, and CC group underwent tumor-building experiments on day 11. Tumorigenicity was then assessed twice a week. After 4 weeks, feces, colon tissue, and tumor tissue were taken from the mice and were tested, and the mice were euthanized afterwards.</p><p><strong>Results: </strong>Mice in the CDHS and CC groups showed symptoms similar to the clinical damp-heat syndrome observed in traditional Chinese medicine (TCM), and exhibited a worse general condition and more rapid tumor growth trend than those in the Mod group. The pathological examination indicated that inflammation was prevalent in the CDHS and CC groups. Both groups had a disrupted intestinal barrier and an overgrowth of pathogenic bacteria such as <i>c_Gammaproteobacteria</i>, <i>o_Enterobacteriales</i>, and <i>g_Bacteroides</i>. Their microbiota composition showed greater diversity.</p><p><strong>Conclusions: </strong>Intestinal flora may have a promising future in the discovery of indicators for evaluating a model of damp-heat syndrome in pancreatic cancer.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-16DOI: 10.3390/biomedicines12102356
Patrycja Paluszkiewicz, Adrian Martuszewski, Jadwiga Radziejewska, Jacek Zawadzki, Jacek Smereka, Jacek Gajek
Background: His bundle pacing (HBP) and left bundle branch pacing (LBBP) are emerging therapies for patients with heart failure and conduction disorders, offering potential advantages over traditional pacing methods. These approaches aim to restore physiological conduction and improve cardiac function more effectively.
Objective: This study aims to evaluate the efficacy and safety of HBP and LBBP in patients with heart failure and conduction disturbances, comparing these techniques to conventional pacing.
Methods: A comprehensive review of recent studies and clinical trials was conducted, focusing on the performance of HBP and LBBP in improving cardiac function, reducing QRS duration, and enhancing overall patient outcomes. The analysis includes data on clinical efficacy, procedural safety, and long-term benefits associated with these pacing modalities.
Results: Both HBP and LBBP have demonstrated significant improvements in cardiac function and clinical outcomes compared to conventional pacing. HBP effectively restores physiological conduction with improved synchronization and a reduction in QRS duration. LBBP has shown enhanced left ventricular activation, leading to better overall cardiac performance. Both techniques have been associated with a lower incidence of complications and a higher success rate in achieving optimal pacing thresholds.
Conclusions: HBP and LBBP offer promising alternatives to traditional pacing for patients with heart failure and conduction disorders. These advanced pacing strategies provide superior clinical outcomes and improved cardiac function with reduced risk of complications. Further research and clinical trials are needed to fully establish the long-term benefits and safety profiles of these techniques in diverse patient populations.
{"title":"His Bundle Pacing and Left Bundle Branch Pacing in Patients with Heart Failure.","authors":"Patrycja Paluszkiewicz, Adrian Martuszewski, Jadwiga Radziejewska, Jacek Zawadzki, Jacek Smereka, Jacek Gajek","doi":"10.3390/biomedicines12102356","DOIUrl":"10.3390/biomedicines12102356","url":null,"abstract":"<p><strong>Background: </strong>His bundle pacing (HBP) and left bundle branch pacing (LBBP) are emerging therapies for patients with heart failure and conduction disorders, offering potential advantages over traditional pacing methods. These approaches aim to restore physiological conduction and improve cardiac function more effectively.</p><p><strong>Objective: </strong>This study aims to evaluate the efficacy and safety of HBP and LBBP in patients with heart failure and conduction disturbances, comparing these techniques to conventional pacing.</p><p><strong>Methods: </strong>A comprehensive review of recent studies and clinical trials was conducted, focusing on the performance of HBP and LBBP in improving cardiac function, reducing QRS duration, and enhancing overall patient outcomes. The analysis includes data on clinical efficacy, procedural safety, and long-term benefits associated with these pacing modalities.</p><p><strong>Results: </strong>Both HBP and LBBP have demonstrated significant improvements in cardiac function and clinical outcomes compared to conventional pacing. HBP effectively restores physiological conduction with improved synchronization and a reduction in QRS duration. LBBP has shown enhanced left ventricular activation, leading to better overall cardiac performance. Both techniques have been associated with a lower incidence of complications and a higher success rate in achieving optimal pacing thresholds.</p><p><strong>Conclusions: </strong>HBP and LBBP offer promising alternatives to traditional pacing for patients with heart failure and conduction disorders. These advanced pacing strategies provide superior clinical outcomes and improved cardiac function with reduced risk of complications. Further research and clinical trials are needed to fully establish the long-term benefits and safety profiles of these techniques in diverse patient populations.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer (PCa) imaging, overcoming conventional imaging and prostate-specific antigen (PSA) serum levels, and has recently emerged as a promising technique for monitoring therapy response in metastatic castration-resistant prostate cancer (mCRPC) patients treated with novel hormonal therapy, taxanes, and radioligand therapy (RLT). In this review, we aim to provide an overview of the most relevant aspects under study and future prospects related to the prognostic role of PSMA PET/CT in mCRPC.
Methods: A systematic literature search was performed in the following databases: MEDLINE, PubMed, and EMBASE databases. The study focused exclusively on English-language studies, excluding papers not pertinent to the topic.
Results: PSMA PET imaging offers a higher sensitivity and specificity than conventional imaging and provides accurate staging and efficient diagnosis of distant metastases. The data presented herein highlight the usefulness of PET in risk stratification, with a prognostic potential that can have a significant impact on clinical practice. Several prospective trials are ongoing and will shortly provide more evidence supporting the prognostic potential of PET PSMA data in this clinical scenario.
Conclusions: Current evidence proves the prognostic role of PSMA PET/CT in different settings, with raising relevance also in the context of mCRPC.
目的:前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)已在前列腺癌(PCa)成像中占据主要地位,超越了传统成像和前列腺特异性抗原(PSA)血清水平,最近已成为监测接受新型激素疗法、类固醇类药物和放射性配体疗法(RLT)治疗的转移性耐受性前列腺癌(mCRPC)患者治疗反应的一种有前途的技术。在这篇综述中,我们旨在概述与PSMA PET/CT在mCRPC中的预后作用有关的最相关的研究内容和未来前景:在以下数据库中进行了系统的文献检索:方法:在以下数据库中进行了系统的文献检索:MEDLINE、PubMed 和 EMBASE 数据库。研究只关注英文研究,排除了与主题无关的论文:与传统成像相比,PSMA PET 成像具有更高的灵敏度和特异性,可提供准确的分期和有效的远处转移诊断。本文提供的数据凸显了 PET 在风险分层中的作用,其预后潜力可对临床实践产生重大影响。几项前瞻性试验正在进行中,不久将提供更多证据支持 PET PSMA 数据在这种临床情况下的预后潜力:目前的证据证明了PSMA PET/CT在不同情况下的预后作用,在mCRPC方面也具有更高的相关性。
{"title":"Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview.","authors":"Matteo Caracciolo, Angelo Castello, Massimo Castellani, Mirco Bartolomei, Egesta Lopci","doi":"10.3390/biomedicines12102355","DOIUrl":"10.3390/biomedicines12102355","url":null,"abstract":"<p><strong>Objectives: </strong>Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer (PCa) imaging, overcoming conventional imaging and prostate-specific antigen (PSA) serum levels, and has recently emerged as a promising technique for monitoring therapy response in metastatic castration-resistant prostate cancer (mCRPC) patients treated with novel hormonal therapy, taxanes, and radioligand therapy (RLT). In this review, we aim to provide an overview of the most relevant aspects under study and future prospects related to the prognostic role of PSMA PET/CT in mCRPC.</p><p><strong>Methods: </strong>A systematic literature search was performed in the following databases: MEDLINE, PubMed, and EMBASE databases. The study focused exclusively on English-language studies, excluding papers not pertinent to the topic.</p><p><strong>Results: </strong>PSMA PET imaging offers a higher sensitivity and specificity than conventional imaging and provides accurate staging and efficient diagnosis of distant metastases. The data presented herein highlight the usefulness of PET in risk stratification, with a prognostic potential that can have a significant impact on clinical practice. Several prospective trials are ongoing and will shortly provide more evidence supporting the prognostic potential of PET PSMA data in this clinical scenario.</p><p><strong>Conclusions: </strong>Current evidence proves the prognostic role of PSMA PET/CT in different settings, with raising relevance also in the context of mCRPC.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-16DOI: 10.3390/biomedicines12102363
Daniel Rivera, Tirone Young, Akhil Rao, Jack Y Zhang, Cole Brown, Lily Huo, Tyree Williams, Benjamin Rodriguez, Alexander J Schupper
Background: Neurosurgery demands exceptional precision due to the brain's complex and delicate structures, necessitating precise targeting of pathological targets. Achieving optimal outcomes depends on the surgeon's ability to accurately differentiate between healthy and pathological tissues during operations. Raman spectroscopy (RS) has emerged as a promising innovation, offering real-time, in vivo non-invasive biochemical tissue characterization. This literature review evaluates the current research on RS applications in intraoperative neurosurgery, emphasizing its potential to enhance surgical precision and patient outcomes.
Methods: Following PRISMA guidelines, a comprehensive systematic review was conducted using PubMed to extract relevant peer-reviewed articles. The inclusion criteria focused on original research discussing real-time RS applications with human tissue samples in or near the operating room, excluding retrospective studies, reviews, non-human research, and other non-relevant publications.
Results: Our findings demonstrate that RS significantly improves tumor margin delineation, with handheld devices achieving high sensitivity and specificity. Stimulated Raman Histology (SRH) provides rapid, high-resolution tissue images comparable to traditional histopathology but with reduced time to diagnosis. Additionally, RS shows promise in identifying tumor types and grades, aiding precise surgical decision-making. RS techniques have been particularly beneficial in enhancing the accuracy of glioma surgeries, where distinguishing between tumor and healthy tissue is critical. By providing real-time molecular data, RS aids neurosurgeons in maximizing the extent of resection (EOR) while minimizing damage to normal brain tissue, potentially improving patient outcomes and reducing recurrence rates.
Conclusions: This review underscores the transformative potential of RS in neurosurgery, advocating for continued innovation and research to fully realize its benefits. Despite its substantial potential, further research is needed to validate RS's clinical utility and cost-effectiveness.
{"title":"Current Applications of Raman Spectroscopy in Intraoperative Neurosurgery.","authors":"Daniel Rivera, Tirone Young, Akhil Rao, Jack Y Zhang, Cole Brown, Lily Huo, Tyree Williams, Benjamin Rodriguez, Alexander J Schupper","doi":"10.3390/biomedicines12102363","DOIUrl":"10.3390/biomedicines12102363","url":null,"abstract":"<p><strong>Background: </strong>Neurosurgery demands exceptional precision due to the brain's complex and delicate structures, necessitating precise targeting of pathological targets. Achieving optimal outcomes depends on the surgeon's ability to accurately differentiate between healthy and pathological tissues during operations. Raman spectroscopy (RS) has emerged as a promising innovation, offering real-time, in vivo non-invasive biochemical tissue characterization. This literature review evaluates the current research on RS applications in intraoperative neurosurgery, emphasizing its potential to enhance surgical precision and patient outcomes.</p><p><strong>Methods: </strong>Following PRISMA guidelines, a comprehensive systematic review was conducted using PubMed to extract relevant peer-reviewed articles. The inclusion criteria focused on original research discussing real-time RS applications with human tissue samples in or near the operating room, excluding retrospective studies, reviews, non-human research, and other non-relevant publications.</p><p><strong>Results: </strong>Our findings demonstrate that RS significantly improves tumor margin delineation, with handheld devices achieving high sensitivity and specificity. Stimulated Raman Histology (SRH) provides rapid, high-resolution tissue images comparable to traditional histopathology but with reduced time to diagnosis. Additionally, RS shows promise in identifying tumor types and grades, aiding precise surgical decision-making. RS techniques have been particularly beneficial in enhancing the accuracy of glioma surgeries, where distinguishing between tumor and healthy tissue is critical. By providing real-time molecular data, RS aids neurosurgeons in maximizing the extent of resection (EOR) while minimizing damage to normal brain tissue, potentially improving patient outcomes and reducing recurrence rates.</p><p><strong>Conclusions: </strong>This review underscores the transformative potential of RS in neurosurgery, advocating for continued innovation and research to fully realize its benefits. Despite its substantial potential, further research is needed to validate RS's clinical utility and cost-effectiveness.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102351
Irina G Kalashnikova, Alexandra I Nekrasova, Anna V Korobeynikova, Maria M Bobrova, German A Ashniev, Sirozhdin Yu Bakoev, Angelica V Zagainova, Mariya V Lukashina, Larisa R Tolkacheva, Ekaterina S Petryaikina, Alexander S Nekrasov, Sergey I Mitrofanov, Tatyana A Shpakova, Lidiya V Frolova, Natalya V Bulanova, Ekaterina A Snigir, Vladimir E Mukhin, Vladimir S Yudin, Valentin V Makarov, Anton A Keskinov, Sergey M Yudin
Background. Currently, it is known that the gut microbiota plays an important role in the functioning of the immune system, and a rebalancing of the bacterial community can arouse complex immune reactions and lead to immune-mediated responses in an organism, in particular, the development of atopic dermatitis (AD). Cytokines and chemokines are regulators of the innate and adaptive immune response and represent the most important biomarkers of the immune system. It is known that changes in cytokine profiles are a hallmark of many diseases, including atopy. However, it remains unclear how the bacterial imbalance disrupts the function of the immune response in AD. Objectives. We attempted to determine the role of gut bacteria in modulating cytokine pathways and their role in atopic inflammation. Methods. We sequenced the 16S rRNA gene from 50 stool samples of children aged 3-12 years who had confirmed atopic dermatitis, and 50 samples from healthy children to serve as a control group. To evaluate the immune status, we conducted a multiplex immunofluorescence assay and measured the levels of 41 cytokines and chemokines in the serum of all participants. Results. To find out whether changes in the composition of the gut microbiota were significantly associated with changes in the level of inflammatory cytokines, a correlation was calculated between each pair of bacterial family and cytokine. In the AD group, 191 correlations were significant (Spearman's correlation coefficient, p ≤ 0.05), 85 of which were positive and 106 which were negative. Conclusions. It has been demonstrated that intestinal dysbiosis is associated with alterations in cytokine profiles, specifically an increase in proinflammatory cytokine concentrations. This may indicate a systemic impact of these conditions, leading to an imbalance in the immune system's response to the Th2 type. As a result, atopic conditions may develop. Additionally, a correlation between known AD biomarkers (IL-5, IL-8, IL-13, CCL22, IFN-γ, TNF-α) and alterations in the abundance of bacterial families (Pasteurellaceae, Barnesiellaceae, Eubacteriaceae) was observed.
{"title":"The Association between Gut Microbiota and Serum Biomarkers in Children with Atopic Dermatitis.","authors":"Irina G Kalashnikova, Alexandra I Nekrasova, Anna V Korobeynikova, Maria M Bobrova, German A Ashniev, Sirozhdin Yu Bakoev, Angelica V Zagainova, Mariya V Lukashina, Larisa R Tolkacheva, Ekaterina S Petryaikina, Alexander S Nekrasov, Sergey I Mitrofanov, Tatyana A Shpakova, Lidiya V Frolova, Natalya V Bulanova, Ekaterina A Snigir, Vladimir E Mukhin, Vladimir S Yudin, Valentin V Makarov, Anton A Keskinov, Sergey M Yudin","doi":"10.3390/biomedicines12102351","DOIUrl":"10.3390/biomedicines12102351","url":null,"abstract":"<p><p><b>Background.</b> Currently, it is known that the gut microbiota plays an important role in the functioning of the immune system, and a rebalancing of the bacterial community can arouse complex immune reactions and lead to immune-mediated responses in an organism, in particular, the development of atopic dermatitis (AD). Cytokines and chemokines are regulators of the innate and adaptive immune response and represent the most important biomarkers of the immune system. It is known that changes in cytokine profiles are a hallmark of many diseases, including atopy. However, it remains unclear how the bacterial imbalance disrupts the function of the immune response in AD. <b>Objectives</b>. We attempted to determine the role of gut bacteria in modulating cytokine pathways and their role in atopic inflammation. <b>Methods.</b> We sequenced the 16S rRNA gene from 50 stool samples of children aged 3-12 years who had confirmed atopic dermatitis, and 50 samples from healthy children to serve as a control group. To evaluate the immune status, we conducted a multiplex immunofluorescence assay and measured the levels of 41 cytokines and chemokines in the serum of all participants. <b>Results.</b> To find out whether changes in the composition of the gut microbiota were significantly associated with changes in the level of inflammatory cytokines, a correlation was calculated between each pair of bacterial family and cytokine. In the AD group, 191 correlations were significant (Spearman's correlation coefficient, <i>p</i> ≤ 0.05), 85 of which were positive and 106 which were negative. <b>Conclusions</b>. It has been demonstrated that intestinal dysbiosis is associated with alterations in cytokine profiles, specifically an increase in proinflammatory cytokine concentrations. This may indicate a systemic impact of these conditions, leading to an imbalance in the immune system's response to the Th2 type. As a result, atopic conditions may develop. Additionally, a correlation between known AD biomarkers (IL-5, IL-8, IL-13, CCL22, IFN-γ, TNF-α) and alterations in the abundance of bacterial families (<i>Pasteurellaceae, Barnesiellaceae, Eubacteriaceae</i>) was observed.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102347
Bence Pál Barta, Benita Onhausz, Abigél Egyed-Kolumbán, Afnan Al Doghmi, János Balázs, Zita Szalai, Ágnes Ferencz, Edit Hermesz, Mária Bagyánszki, Nikolett Bódi
Background/objectives: Type 1 diabetes affects cytokines as potential inducers of NFκB signalling involved in inflammation and neuronal survival. Our goal was to assess the expression of NFκB p65 and its negative regulator, Nrf2, in myenteric neurons and adjacent smooth muscle of different gut segments after chronic hyperglycaemia and immediate insulin treatment.
Methods: After ten weeks of hyperglycaemia, intestinal samples of control, streptozotocin-induced diabetic and insulin-treated diabetic rats were prepared for fluorescent immunohistochemistry, immunogold electron microscopy, ELISA and qPCR.
Results: In the diabetic rats, the proportion of NFκB p65-immunoreactive myenteric neurons decreased significantly in the duodenum and increased in the ileum. The density of NFκB p65-labelling gold particles increased in the ileal but remained unchanged in the duodenal ganglia. Meanwhile, both total and nuclear Nrf2 density increased in the myenteric neurons of the diabetic duodenum. In smooth muscle, NFκB p65 and Nrf2 density increased in the small intestine of diabetic rats. While on the mRNA level, NFκB p65 and Nrf2 were induced, on the protein level, NFκB p65 increased and Nrf2 decreased in muscle/myenteric plexus homogenates. Insulin treatment had protective effects.
Conclusions: Our findings reveal a segment-specific NFκB and Nrf expression in myenteric neurons and ganglionic muscular environments, which may contribute to regional neuronal survival and motility disturbances in diabetes.
{"title":"Intestinal Region-Dependent Impact of NFκB-Nrf Crosstalk in Myenteric Neurons and Adjacent Muscle Cells in Type 1 Diabetic Rats.","authors":"Bence Pál Barta, Benita Onhausz, Abigél Egyed-Kolumbán, Afnan Al Doghmi, János Balázs, Zita Szalai, Ágnes Ferencz, Edit Hermesz, Mária Bagyánszki, Nikolett Bódi","doi":"10.3390/biomedicines12102347","DOIUrl":"10.3390/biomedicines12102347","url":null,"abstract":"<p><strong>Background/objectives: </strong>Type 1 diabetes affects cytokines as potential inducers of NFκB signalling involved in inflammation and neuronal survival. Our goal was to assess the expression of NFκB p65 and its negative regulator, Nrf2, in myenteric neurons and adjacent smooth muscle of different gut segments after chronic hyperglycaemia and immediate insulin treatment.</p><p><strong>Methods: </strong>After ten weeks of hyperglycaemia, intestinal samples of control, streptozotocin-induced diabetic and insulin-treated diabetic rats were prepared for fluorescent immunohistochemistry, immunogold electron microscopy, ELISA and qPCR.</p><p><strong>Results: </strong>In the diabetic rats, the proportion of NFκB p65-immunoreactive myenteric neurons decreased significantly in the duodenum and increased in the ileum. The density of NFκB p65-labelling gold particles increased in the ileal but remained unchanged in the duodenal ganglia. Meanwhile, both total and nuclear Nrf2 density increased in the myenteric neurons of the diabetic duodenum. In smooth muscle, NFκB p65 and Nrf2 density increased in the small intestine of diabetic rats. While on the mRNA level, NFκB p65 and Nrf2 were induced, on the protein level, NFκB p65 increased and Nrf2 decreased in muscle/myenteric plexus homogenates. Insulin treatment had protective effects.</p><p><strong>Conclusions: </strong>Our findings reveal a segment-specific NFκB and Nrf expression in myenteric neurons and ganglionic muscular environments, which may contribute to regional neuronal survival and motility disturbances in diabetes.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102350
Matteo Scanu, Federica Del Chierico, Riccardo Marsiglia, Francesca Toto, Silvia Guerrera, Giovanni Valeri, Stefano Vicari, Lorenza Putignani
Background: To date, there have been numerous metataxonomic studies on gut microbiota (GM) profiling based on the analyses of data from public repositories. However, differences in study population and wet and dry pipelines have produced discordant results. Herein, we propose a biostatistical approach to remove these batch effects for the GM characterization in the case of autism spectrum disorders (ASDs).
Methods: An original dataset of GM profiles from patients with ASD was ecologically characterized and compared with GM public digital profiles of age-matched neurotypical controls (NCs). Also, GM data from seven case-control studies on ASD were retrieved from the NCBI platform and exploited for analysis. Hence, on each dataset, conditional quantile regression (CQR) was performed to reduce the batch effects originating from both technical and geographical confounders affecting the GM-related data. This method was further applied to the whole dataset matrix, obtained by merging all datasets. The ASD GM markers were identified by the random forest (RF) model.
Results: We observed a different GM profile in patients with ASD compared with NC subjects. Moreover, a significant reduction of technical- and geographical-dependent batch effects in all datasets was achieved. We identified Bacteroides_H, Faecalibacterium, Gemmiger_A_73129, Blautia_A_141781, Bifidobacterium_388775, and Phocaeicola_A_858004 as robust GM bacterial biomarkers of ASD. Finally, our validation approach provided evidence of the validity of the QCR method, showing high values of accuracy, specificity, sensitivity, and AUC-ROC.
Conclusions: Herein, we proposed an updated biostatistical approach to reduce the technical and geographical batch effects that may negatively affect the description of bacterial composition in microbiota studies.
{"title":"Correction of Batch Effect in Gut Microbiota Profiling of ASD Cohorts from Different Geographical Origins.","authors":"Matteo Scanu, Federica Del Chierico, Riccardo Marsiglia, Francesca Toto, Silvia Guerrera, Giovanni Valeri, Stefano Vicari, Lorenza Putignani","doi":"10.3390/biomedicines12102350","DOIUrl":"10.3390/biomedicines12102350","url":null,"abstract":"<p><strong>Background: </strong>To date, there have been numerous metataxonomic studies on gut microbiota (GM) profiling based on the analyses of data from public repositories. However, differences in study population and wet and dry pipelines have produced discordant results. Herein, we propose a biostatistical approach to remove these batch effects for the GM characterization in the case of autism spectrum disorders (ASDs).</p><p><strong>Methods: </strong>An original dataset of GM profiles from patients with ASD was ecologically characterized and compared with GM public digital profiles of age-matched neurotypical controls (NCs). Also, GM data from seven case-control studies on ASD were retrieved from the NCBI platform and exploited for analysis. Hence, on each dataset, conditional quantile regression (CQR) was performed to reduce the batch effects originating from both technical and geographical confounders affecting the GM-related data. This method was further applied to the whole dataset matrix, obtained by merging all datasets. The ASD GM markers were identified by the random forest (RF) model.</p><p><strong>Results: </strong>We observed a different GM profile in patients with ASD compared with NC subjects. Moreover, a significant reduction of technical- and geographical-dependent batch effects in all datasets was achieved. We identified <i>Bacteroides_H</i>, <i>Faecalibacterium</i>, <i>Gemmiger_A_73129</i>, <i>Blautia_A_141781</i>, <i>Bifidobacterium_388775</i>, and <i>Phocaeicola_A_858004</i> as robust GM bacterial biomarkers of ASD. Finally, our validation approach provided evidence of the validity of the QCR method, showing high values of accuracy, specificity, sensitivity, and AUC-ROC.</p><p><strong>Conclusions: </strong>Herein, we proposed an updated biostatistical approach to reduce the technical and geographical batch effects that may negatively affect the description of bacterial composition in microbiota studies.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102343
Zuly A Sánchez-Florentino, Bianca S Romero-Martínez, Edgar Flores-Soto, Luis M Montaño, Bettina Sommer, Marcela Valdés-Tovar, Jesús Argueta, Eduardo Calixto, Arnoldo Aquino-Gálvez, Manuel Castillejos-López, Héctor Serrano, Juan C Gomez-Verjan, Germán O López-Riquelme, Gloria A Benítez-King, Ruth Jaimez, Héctor Solís-Chagoyán
Background: Schizophrenia (SZ) is a multifactorial chronic psychiatric disorder with a worldwide prevalence of 1%. Altered expression of PLCβ occurs in SZ patients, suggesting alterations in the PLCβ/IP3/Ca2+ signaling pathway. This cascade regulates critical cellular processes in all cell types, including the neuronal lineage; however, there is scarce evidence regarding the functionality of this transduction signaling in neuronal cells derived from SZ patients. Objective: We evaluated the functionality of the PLCβ/IP3/Ca2+ pathway in olfactory neuronal precursor cells (hONPCs) obtained from SZ patients. Methods: Cryopreserved hONPCs isolated from SZ patients and healthy subjects (HS) were thawed. The cellular types in subcultures were corroborated by immunodetection of the multipotency and lineage markers SOX-2, Musashi-1, nestin, and β-III tubulin. The PLCβ/IP3/Ca2+ pathway was activated by GPCR (Gq) ligands (ATP, UTP, serotonin, and epinephrine). In addition, PLCβ and IP3R were directly stimulated by perfusing cells with the activators m-3M3FBS and ADA, respectively. Cytosolic Ca2+ was measured by microfluorometry and by Ca2+ imaging. The amount and subcellular distribution of the PLCβ1 and PLCβ3 isoforms were evaluated by confocal immunofluorescence. IP3 concentration was measured by ELISA. Results: The results show that the increase of cytosolic Ca2+ triggered by GPCR ligands or directly through either PLCβ or IP3R activation was significantly lower in SZ-derived hONPCs, regarding HS-derived cells. Moreover, the relative amount of the PLCβ1 and PLCβ3 isoforms and IP3 production stimulated with m-3M3FBS were reduced in SZ-derived cells. Conclusions: Our results suggest an overall functional impairment in the PLCβ/IP3/Ca2+ signaling pathway in SZ-derived hONPCs.
{"title":"Altered PLCβ/IP<sub>3</sub>/Ca<sup>2+</sup> Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia.","authors":"Zuly A Sánchez-Florentino, Bianca S Romero-Martínez, Edgar Flores-Soto, Luis M Montaño, Bettina Sommer, Marcela Valdés-Tovar, Jesús Argueta, Eduardo Calixto, Arnoldo Aquino-Gálvez, Manuel Castillejos-López, Héctor Serrano, Juan C Gomez-Verjan, Germán O López-Riquelme, Gloria A Benítez-King, Ruth Jaimez, Héctor Solís-Chagoyán","doi":"10.3390/biomedicines12102343","DOIUrl":"10.3390/biomedicines12102343","url":null,"abstract":"<p><p><b>Background</b>: Schizophrenia (SZ) is a multifactorial chronic psychiatric disorder with a worldwide prevalence of 1%. Altered expression of PLCβ occurs in SZ patients, suggesting alterations in the PLCβ/IP<sub>3</sub>/Ca<sup>2+</sup> signaling pathway. This cascade regulates critical cellular processes in all cell types, including the neuronal lineage; however, there is scarce evidence regarding the functionality of this transduction signaling in neuronal cells derived from SZ patients. <b>Objective</b>: We evaluated the functionality of the PLCβ/IP<sub>3</sub>/Ca<sup>2+</sup> pathway in olfactory neuronal precursor cells (hONPCs) obtained from SZ patients. <b>Methods</b>: Cryopreserved hONPCs isolated from SZ patients and healthy subjects (HS) were thawed. The cellular types in subcultures were corroborated by immunodetection of the multipotency and lineage markers SOX-2, Musashi-1, nestin, and β-III tubulin. The PLCβ/IP<sub>3</sub>/Ca<sup>2+</sup> pathway was activated by GPCR (G<sub>q</sub>) ligands (ATP, UTP, serotonin, and epinephrine). In addition, PLCβ and IP<sub>3</sub>R were directly stimulated by perfusing cells with the activators m-3M3FBS and ADA, respectively. Cytosolic Ca<sup>2+</sup> was measured by microfluorometry and by Ca<sup>2+</sup> imaging. The amount and subcellular distribution of the PLCβ1 and PLCβ3 isoforms were evaluated by confocal immunofluorescence. IP<sub>3</sub> concentration was measured by ELISA. <b>Results</b>: The results show that the increase of cytosolic Ca<sup>2+</sup> triggered by GPCR ligands or directly through either PLCβ or IP<sub>3</sub>R activation was significantly lower in SZ-derived hONPCs, regarding HS-derived cells. Moreover, the relative amount of the PLCβ1 and PLCβ3 isoforms and IP<sub>3</sub> production stimulated with m-3M3FBS were reduced in SZ-derived cells. <b>Conclusions</b>: Our results suggest an overall functional impairment in the PLCβ/IP<sub>3</sub>/Ca<sup>2+</sup> signaling pathway in SZ-derived hONPCs.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102345
Suryadipto Sarkar, Teresa Wu, Matthew Harwood, Alvin C Silva
Background: Prostate cancer is the second most common new cancer diagnosis in the United States. It is usually slow-growing, and when it is low-grade and confined to the prostate gland, it can be treated either conservatively (through active surveillance) or with surgery. However, if the cancer has spread beyond the prostate, such as to the lymph nodes, then that indicates a more aggressive cancer, and surgery may not be adequate. Methods: The challenge is that it is often difficult for radiologists reading prostate-specific imaging such as magnetic resonance images (MRIs) to differentiate malignant lymph nodes from non-malignant ones. An emerging field is the development of artificial intelligence (AI) models, including machine learning and deep learning, for medical imaging to assist in diagnostic tasks. Earlier research focused on implementing texture algorithms to extract imaging features used in classification models. More recently, researchers began studying the use of deep learning for both stand-alone feature extraction and end-to-end classification tasks. In order to tackle the challenges inherent in small datasets, this study was designed as a scalable hybrid framework utilizing pre-trained ResNet-18, a deep learning model, to extract features that were subsequently fed into a machine learning classifier to automatically identify malignant lymph nodes in patients with prostate cancer. For comparison, two texture algorithms were implemented, namely the gray-level co-occurrence matrix (GLCM) and Gabor. Results: Using an institutional prostate lymph node dataset (42 positives, 84 negatives), the proposed framework achieved an accuracy of 76.19%, a sensitivity of 79.76%, and a specificity of 69.05%. Using GLCM features, the classification achieved an accuracy of 61.90%, a sensitivity of 74.07%, and a specificity of 42.86%. Using Gabor features, the classification achieved an accuracy of 65.08%, a sensitivity of 73.47%, and a specificity of 52.50%. Conclusions: Our results demonstrate that a hybrid approach, i.e., using a pre-trainined deep learning model for feature extraction, followed by a machine learning classifier, is a viable solution. This hybrid approach is especially useful in medical-imaging-based applications with small datasets.
{"title":"A Transfer Learning-Based Framework for Classifying Lymph Node Metastasis in Prostate Cancer Patients.","authors":"Suryadipto Sarkar, Teresa Wu, Matthew Harwood, Alvin C Silva","doi":"10.3390/biomedicines12102345","DOIUrl":"10.3390/biomedicines12102345","url":null,"abstract":"<p><p><b>Background:</b> Prostate cancer is the second most common new cancer diagnosis in the United States. It is usually slow-growing, and when it is low-grade and confined to the prostate gland, it can be treated either conservatively (through active surveillance) or with surgery. However, if the cancer has spread beyond the prostate, such as to the lymph nodes, then that indicates a more aggressive cancer, and surgery may not be adequate. <b>Methods:</b> The challenge is that it is often difficult for radiologists reading prostate-specific imaging such as magnetic resonance images (MRIs) to differentiate malignant lymph nodes from non-malignant ones. An emerging field is the development of artificial intelligence (AI) models, including machine learning and deep learning, for medical imaging to assist in diagnostic tasks. Earlier research focused on implementing texture algorithms to extract imaging features used in classification models. More recently, researchers began studying the use of deep learning for both stand-alone feature extraction and end-to-end classification tasks. In order to tackle the challenges inherent in small datasets, this study was designed as a scalable hybrid framework utilizing pre-trained ResNet-18, a deep learning model, to extract features that were subsequently fed into a machine learning classifier to automatically identify malignant lymph nodes in patients with prostate cancer. For comparison, two texture algorithms were implemented, namely the gray-level co-occurrence matrix (GLCM) and Gabor. <b>Results:</b> Using an institutional prostate lymph node dataset (42 positives, 84 negatives), the proposed framework achieved an accuracy of 76.19%, a sensitivity of 79.76%, and a specificity of 69.05%. Using GLCM features, the classification achieved an accuracy of 61.90%, a sensitivity of 74.07%, and a specificity of 42.86%. Using Gabor features, the classification achieved an accuracy of 65.08%, a sensitivity of 73.47%, and a specificity of 52.50%. <b>Conclusions:</b> Our results demonstrate that a hybrid approach, i.e., using a pre-trainined deep learning model for feature extraction, followed by a machine learning classifier, is a viable solution. This hybrid approach is especially useful in medical-imaging-based applications with small datasets.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.3390/biomedicines12102340
Jie Zhang, Huilin Gan, Xiaoyan Duan, Guangming Li
Over the past decade, there has been a rapid increase in the incidence of inflammatory bowel disease. It has been suggested that multifactorial interactions of environmental factors, genetic factors, immune response and intestinal microbiota are involved in the pathogenesis of inflammatory bowel disease. It is widely recognized that the intestinal microbiota are essential for human metabolism, the immune system and pathogen resistance, and are integral to human health. Therefore, the dysbiosis of the microbiota is a critical step leading to intestinal mucosal damage and a key factor in the pathogenesis of inflammatory bowel disease. Regulating the microbiota through interventions such as enteral nutrition, fecal microbiota transplantation, and probiotic supplementation has the potential to prevent or even reverse intestinal dysbiosis, opening up new perspectives for the treatment of inflammatory bowel disease.
{"title":"Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease.","authors":"Jie Zhang, Huilin Gan, Xiaoyan Duan, Guangming Li","doi":"10.3390/biomedicines12102340","DOIUrl":"10.3390/biomedicines12102340","url":null,"abstract":"<p><p>Over the past decade, there has been a rapid increase in the incidence of inflammatory bowel disease. It has been suggested that multifactorial interactions of environmental factors, genetic factors, immune response and intestinal microbiota are involved in the pathogenesis of inflammatory bowel disease. It is widely recognized that the intestinal microbiota are essential for human metabolism, the immune system and pathogen resistance, and are integral to human health. Therefore, the dysbiosis of the microbiota is a critical step leading to intestinal mucosal damage and a key factor in the pathogenesis of inflammatory bowel disease. Regulating the microbiota through interventions such as enteral nutrition, fecal microbiota transplantation, and probiotic supplementation has the potential to prevent or even reverse intestinal dysbiosis, opening up new perspectives for the treatment of inflammatory bowel disease.</p>","PeriodicalId":8937,"journal":{"name":"Biomedicines","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142494377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}